NeuroPace (NPCE) Cash & Current Investments (2020 - 2026)

NeuroPace's (NPCE) quarterly Cash & Current Investments came in at $54.0 million in Q1 2026, down 18.53% year-on-year from $66.3 million in Q1 2025, and down 11.59% quarter-over-quarter from $61.1 million in Q4 2025.

NeuroPace (NPCE) Cash & Current Investments (2020 - 2026) Analysis & Trends

NeuroPace's Cash & Current Investments history runs 7 years deep, the most recent figure standing at $54.0 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 18.53% year-over-year to $54.0 million in Q1 2026; TTM through Mar 2026 was $54.0 million, a 18.53% decrease from a year earlier, with the FY2025 full-year figure at $61.1 million, up 15.74% from the prior year.
  • Cash & Current Investments slipped to $54.0 million in Q1 2026 per NPCE's latest filing, from $61.1 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $103.2 million in Q1 2022 and bottomed at $52.8 million in Q4 2024.
  • The 5-year median for Cash & Current Investments is $62.1 million (2025), against an average of $67.3 million.
  • Across the five-year window, Cash & Current Investments jumped 237.95% in 2022 and sank 34.47% in 2023, its largest moves.
  • Year by year, Cash & Current Investments stood at $77.4 million in 2022, then decreased by 14.15% to $66.5 million in 2023, then declined by 20.61% to $52.8 million in 2024, then increased by 15.74% to $61.1 million in 2025, then dropped by 11.59% to $54.0 million in 2026.
  • Per Business Quant, the three latest NPCE Cash & Current Investments figures stand at $54.0 million (Q1 2026), $61.1 million (Q4 2025), and $60.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 7.30 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 2.88 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 9.22 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 3.67 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 1.12 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 3.12 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 2.29 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 577.00 Mn
10 NeuroPace 494.96 Mn 440.98 Mn 18.05 Mn 53.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 53.98 Mn
Dec 31, 2025 61.06 Mn
Sep 30, 2025 60.01 Mn
Jun 30, 2025 62.14 Mn
Mar 31, 2025 66.26 Mn
Dec 31, 2024 52.76 Mn
Sep 30, 2024 56.83 Mn
Jun 30, 2024 55.54 Mn
Mar 31, 2024 58.95 Mn
Dec 31, 2023 66.45 Mn
Sep 30, 2023 61.35 Mn
Jun 30, 2023 63.57 Mn
Mar 31, 2023 67.62 Mn
Dec 31, 2022 77.41 Mn
Sep 30, 2022 85.41 Mn
Jun 30, 2022 92.41 Mn
Mar 31, 2022 103.18 Mn
Dec 31, 2021 115.58 Mn
Sep 30, 2021 123.33 Mn
Jun 30, 2021 127.92 Mn